Assessing the tolerability and health benefits of soluble tapioca fibre: Phase One

Not Applicable

• Conditions: Gastrointestinal Tolerability; Diet and Nutrition - Other diet and nutrition disorders; Oral and Gastrointestinal - Normal oral and gastrointestinal development and function

• Registration Number: ACTRN12620000142932
• Lead Sponsor: Murdoch University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-02-12
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Individuals without clinically diagnosed diseases with relevant effect on the gastrointestinal system or on visceral motility and agree to keep a detailed dietary for GI symptoms and stool characteristics during both phases of the study.

Exclusion Criteria

Individuals having constipation, defined as 0–3 stools per week for the last 6 weeks; prescription of medication for digestive symptoms such as anti-spasmodic, laxatives, anti-diarrheic drugs or other digestive auxiliaries, relevant history/presence of any medical disorder or intake of medication/dietary supplements potentially interfering with this trial (e.g. irritable bowel syndrome), vegetarians or vegans, intake of antibiotics within 4 weeks before the screening visit and intake of laxatives within 2 weeks before the screening visit.

Study & Design

• Study Type: Interventional
• Study Design: Not specified